International conferences and seminars

3rd Epigenetics in Drug Discovery

GTC's 3rd Epigenetics in Drug Discovery conference is the only epigenetics conference that brings together a balanced mix of leading experts from the industry and academia to collaborate on the latest cutting edge research on novel epigenetic mechanisms, therapeutics, developments, biomarkers and diagnostics. Venture Capitalists will also join the conference to discuss investment opportunities and what they look for in the epigenetics space.

Some key discussions around epigenetics drug discovery at the conference include: 1) The role of epigenetics in human diseases such as cancer, leukaemia, neurodegenerative conditions, neuropsychiatric disorders, inflammation, etc. 2) Novel mechanisms, biomarkers, technologies and diagnostics for epigenetics drug discovery 3) Cutting edge research from GlaxoSmithKline, Epizyme, Genentech, Constellation, Astex, Cellzome, RaNA Therapeutics, Pfizer, Harvard, Massachusetts Institute of Technology, etc.

Conference sessions are:
Epigenetic Mechanisms
Role of Epigenetics in Human Diseases
Drug Discovery in Epigenetics
Preclinical and Clinical Development
Epigenetic Biomarkers and Diagnostics
Panel Discussion: Investment Opportunities in the Epigenetic Space

The conference will run parallel with the other exciting conferences:
7th Drug Design & Medicinal Chemistry
6th Imaging in Drug Discovery & Development
Orphan Drugs Research and Commercialization

Bring a team of 3 for the price of 2 by registering with the coupon code rcdvb!

We look forward to seeing you at the conference!